Abstract deadline April 3 2020
Abstracts should contain the following four components (please bold the four section headings noted below within the text of your abstract submission):
Background: A concise statement of a hypothesis or the issue under investigation
Materials and Methods: The experimental methods used (including the statistical analyses employed)
Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable)
Conclusions: A summary of findings that are supported by your results. Statistical analyses that support the conclusions should be included where appropriate. Concluding statements such as, "the results will be discussed," are not acceptable.
Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements, or literature references are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially.
Those who submit accepted abstracts agree to attend the meeting and present their abstract as scheduled.
Authors can submit their abstracts electronically using the “Submit Abstract Here” button. This will direct you to the appropriate webpage. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Categories for Abstract Submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
We encourage you to submit your abstracts focused on one of the following topics
• HIV infection in pregnant and breastfeeding women
• Prevention of mother-to-child HIV transmission (PMTCT), including HIV-exposed uninfected children
• Pediatric HIV case finding (including early infant diagnosis)
• Antiretroviral treatment of pediatric HIV infection
• Complications of HIV and its treatment in children and youth
• Co-infections in HIV-positive children and youth
• HIV infection and adolescents (perinatally and behaviorally infected)
• Prevention of HIV and STDs in adolescents and young adults
• Implementation science research on optimizing care of children and youth and PMTCT
• Pediatric remission/cure research
Co-submission with AIDS 2020 is allowed
HIV Pediatrics 2020 has an official agreement with the International AIDS Society to allow co-submission of abstracts to HIV Pediatrics 2020 and AIDS 2020 under the conditions of strict compliance with the IAS 2020 embargo policy.
You must indicate this when submitting your abstract for HIV Pediatrics 2020.
We are pleased to offer free registration to young healthcare professionals with an accepted abstract and a discount on the registration fee for young professionals without an accepted abstract.
In order to receive a special registration code, the young investigator needs to ask a supervisor to complete the application form and send it to Rikke Rode (email@example.com) no later than 1 May 2020.
Free registrations/discounts are granted to young investigators in training and those who have obtained an MD/PhD in the last five years.
Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.
An award will be granted to the young investigator with the best abstract. The Scientific Committee and Organizing Committee will judge all submitted abstracts. The award winner will be announced during the second workshop day.
Notification of Abstract Acceptance and Presentation Format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to submitting authors before 1 May. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status.
Please notify the conference secretariat if you have not received notification by 1 May. If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Abstract submitter’s registration guidelines will be sent together with the notification. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.
Accepted abstracts will be published in the conference abstract book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.